American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy

Reddy, K Rajender; Beavers, Kimberly L; Hammond, Sarah P.; Lim, Joseph K.; Falck-Ytter, Yngve T

doi:10.1053/j.gastro.2014.10.039

Record: found
Abstract: not found
Article: not found

American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy

Author(s): K. Rajender Reddy , Kimberly L. Beavers , Sarah P. Hammond , Joseph K. Lim , Yngve T. Falck-Ytter

Publication date Created: January 2015

Publication date (Print): January 2015

Journal: Gastroenterology

Publisher: Elsevier BV

Read this article at

ScienceOpenPublisher PubMed

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Most cited references 2

Record: found
Abstract: not found
Article: not found

American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.

Robert Perrillo, Robert Gish, Yngve Falck-Ytter (2015)

0 comments Cited 165 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: not found
Article: not found

The AGA Institute Process for Developing Clinical Practice Guidelines Part One: Grading the Evidence

Shahnaz Sultan, Yngve Falck-Ytter, John M Inadomi (2013)

0 comments Cited 18 times – based on 0 reviews      Review now

Bookmark

All references

Author and article information

Journal

Title: Gastroenterology

Abbreviated Title: Gastroenterology

Publisher: Elsevier BV

ISSN (Print): 00165085

Publication date Created: January 2015

Publication date (Print): January 2015

Volume: 148

Issue: 1

Pages: 215-219

Article

DOI: 10.1053/j.gastro.2014.10.039

PubMed ID: 25447850

SO-VID: 45171d3b-0d17-4fab-96f4-6d7b08f4b3dc

License:

https://www.elsevier.com/tdm/userlicense/1.0/

History

Data availability:

American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy

Read this article at

Related collections

Karger: Gastroenterology

Most cited references 2

American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.

The AGA Institute Process for Developing Clinical Practice Guidelines Part One: Grading the Evidence

Author and article information

Journal

Article

History

Comments

Comment on this article

Similar content 1,638

Cited by 167

Most referenced authors 10